Skip to main content
Erschienen in: Medical Oncology 2/2009

01.06.2009 | Original Paper

Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy

verfasst von: Yandong Nan, Shuanying Yang, Yingxuan Tian, Wei Zhang, Bin Zhou, Lina Bu, Shufen Huo

Erschienen in: Medical Oncology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to globally screen and identify the expression protein profiles of lung squamous carcinoma cell (SqCC) using shot-gun proteomics strategy and to further analyze function of individual proteins by bioinformatics, which may likely result in the identification of new biomarkers and provide helpful clues for pathogenesis, early diagnosis, and progression of lung SqCC. The specific tumor cells were isolated and collected from the tissues of six patients with lung SqCC by laser capture microdissection (LCM). Total proteins from the LCM cells were extracted, digested with trypsin. The sequence information of resulting peptides was acquired by high-performance liquid chromatography (HPLC) and tandem mass spectrometry (TMS). The global protein profiles of lung SqCC cell were identified with BioworksTM software in IPI human protein database. Cellular component, molecular function, and biological process of the all proteins were analyzed using gene ontology (GO). About 720,000 tumor cells were satisfactorily collected from tissues of six patients with lung SqCC by LCM and the homogeneities of cell population were estimated to be over 95% as determined by microscopic visualization. The high resolution profiles including HPLC, full mass spectrum, and tandem mass spectrum were successfully obtained. Database searching of the resulting bimolecular sequence information identified 1982 proteins in all samples. The bioinformatics of these proteins, including amino acids sequence, fraction of coverage, molecular weight, isoelectric point, etc., were analyzed in detail. Among them, the function of most proteins was recognized by using GO. Five candidate proteins, Prohibitin (PHB), Mitogen-activated protein kinase (MAPK), Heat shock protein27 (HSP27), Annexin A1(ANXA1), and High mobility group protein B1 (HMGB1), might play an important role in SqCC genesis, progression, recurrence, and metastasis according to relative literatures. We have successfully isolated the interesting cells and effectively solved the heterogeneous problem of lung SqCC using LCM. The globally expressional proteins of lung SqCC cell were identified by shot-gun proteomics strategy. The five proteins might be hopefully used as markers of lung SqCC.
Literatur
1.
Zurück zum Zitat Yang DC, Yang SY. The current status and progress of lung cancer diagnosis. Chin J Tuberc Respir Dis. 2004;27:18–9. Yang DC, Yang SY. The current status and progress of lung cancer diagnosis. Chin J Tuberc Respir Dis. 2004;27:18–9.
3.
Zurück zum Zitat Rosell R, et al. Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors. Int J Cancer. 1997;74:330–4. doi:10.1002/(SICI)1097-0215(19970620)74:3<330::AID-IJC17>3.0.CO;2-F.PubMedCrossRef Rosell R, et al. Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors. Int J Cancer. 1997;74:330–4. doi:10.1002/(SICI)1097-0215(19970620)74:3<330::AID-IJC17>3.0.CO;2-F.PubMedCrossRef
4.
Zurück zum Zitat Yang SY, Nan YD, Wen XP. The current situation and progress of lung cancer proteomics study. Int Inspir. 2006;26:471–3. Yang SY, Nan YD, Wen XP. The current situation and progress of lung cancer proteomics study. Int Inspir. 2006;26:471–3.
7.
Zurück zum Zitat Zhukov TA, et al. Discovery of distinct protein profiles specific for lung rumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer. 2003;40:267–79.PubMed Zhukov TA, et al. Discovery of distinct protein profiles specific for lung rumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer. 2003;40:267–79.PubMed
10.
Zurück zum Zitat Wu TF, et al. Prohibitin in the pathogenesis of transitional cell bladder cancer. Anticancer Res. 2007;27:895–900.PubMed Wu TF, et al. Prohibitin in the pathogenesis of transitional cell bladder cancer. Anticancer Res. 2007;27:895–900.PubMed
15.
Zurück zum Zitat Akaike H, et al. Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res. 2007;27:449–57.PubMed Akaike H, et al. Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res. 2007;27:449–57.PubMed
16.
Zurück zum Zitat Kuniyasu H, et al. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol. 2005;166:751–60.PubMed Kuniyasu H, et al. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol. 2005;166:751–60.PubMed
Metadaten
Titel
Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy
verfasst von
Yandong Nan
Shuanying Yang
Yingxuan Tian
Wei Zhang
Bin Zhou
Lina Bu
Shufen Huo
Publikationsdatum
01.06.2009
Verlag
Humana Press Inc
Erschienen in
Medical Oncology / Ausgabe 2/2009
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9109-4

Weitere Artikel der Ausgabe 2/2009

Medical Oncology 2/2009 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.